Nurses Revision

Family Planning

Combined Oral Contraceptive Pill (COC)

Oral pills containing both an estrogen and a progestin hormone, taken daily to prevent pregnancy primarily by inhibiting ovulation.

Also known as: COC, The Pill, Birth Control Pill

View images for Combined Oral Contraceptive Pill (COC) (Google Images, opens in a new tab)
On this page

Referral and warning signs

When to refer

Refer if: Contraindications identified. Development of warning signs (severe headache, chest pain, leg pain etc.). Persistent problematic side effects. Need for alternative method due to drug interactions.

Red flags

  • Severe chest pain or shortness of breath
  • Severe headache, visual changes, neurological symptoms
  • Severe abdominal pain
  • Severe leg pain or swelling
  • Jaundice
  • BP ≥160/100 mmHg

Signs and symptoms

  • Common Side Effects (often improve after first few months): Nausea, vomiting, spotting/irregular bleeding, breast tenderness, headache, dizziness, weight gain (often minor), mood changes.
  • Warning Signs (Complications - require immediate stop and medical attention): Severe headaches (migraine with aura, stroke sign), Blurred vision, Severe chest pain (PE, MI), Severe abdominal pain (gallbladder, liver tumour, clot), Severe leg pain/swelling (DVT), Depression.

Risk factors

  • Contraindications (MEC Category 4 - Do Not Use): Current breast cancer, Severe liver disease (active hepatitis, cirrhosis, tumour), Migraine with aura, Age ≥35 AND Smoking ≥15 cigarettes/day, Multiple risk factors for cardiovascular disease (older age, smoking, diabetes, hypertension), Hypertension ≥160/100 mmHg, History of VTE (DVT/PE), Known thrombogenic mutations, Major surgery with prolonged immobilization, Ischaemic heart disease/Stroke history, Complicated valvular heart disease, <21 days postpartum.
  • Relative Contraindications (MEC Category 3 - Risks outweigh benefits): Age ≥35 AND Smoking <15 cigarettes/day, Hypertension 140-159/90-99 mmHg, Past breast cancer >5yrs ago, Gallbladder disease, Malabsorptive bariatric surgery, Certain drug interactions (Rifampicin, some anticonvulsants).

Diagnosis

Clinical assessment

Eligibility assessment based on medical history, BP check, assessment of risk factors/contraindications using MEC guidelines.

Investigations

  • Blood Pressure measurement (essential).
  • Rule out pregnancy before starting.
  • Assess for contraindications via history.

Diagnostic criteria

Client meets medical eligibility criteria for COC use.

Management

Non-pharmacological management

  • Counseling: Explain mechanism, effectiveness, how to take daily, what to do if pills missed, side effects, warning signs, lack of STI protection.
  • Supply 3 cycles initially.

Pharmacological treatment

  • Standard regimen: Take one pill daily, preferably at same time. Typically 21 active pills followed by 7-day break (or placebo pills), or continuous regimens.
  • Management of Missed Pills: Follow specific instructions based on number missed and week of cycle (refer to packet insert/guidelines - often requires backup contraception).
  • Management of Side Effects:
  • - Nausea: Take with food or at bedtime. Reassure often transient.
  • - Breast Tenderness: Supportive bra, analgesia. Rule out pregnancy.
  • - Mild Headache: Analgesia (Paracetamol, Ibuprofen). Rule out severe headache/migraine with aura.
  • - Irregular Bleeding: Reassure often improves. Rule out other causes (pregnancy, infection). Consider short course NSAIDs. If persistent, may need method change.
  • Drug Interactions: Reduced effectiveness with enzyme inducers (Rifampicin, some anticonvulsants - Phenytoin, Carbamazepine, Barbiturates, Topiramate; some ARVs - Efavirenz, Nevirapine). Requires backup method during and after use of interacting drug. Broad spectrum antibiotics generally do not significantly reduce efficacy, but backup advised if diarrhoea/vomiting occurs.

Monitoring

Follow-up visits for resupply, check BP, assess side effects/problems, reinforce correct use.

Complications

  • Venous Thromboembolism (VTE - DVT/PE) - small increased risk.
  • Arterial Thrombosis (MI, Stroke) - very small increased risk, mainly if other risk factors present.
  • Hypertension (can worsen or develop).
  • Gallbladder disease.
  • Liver tumours (benign adenomas, rare malignant) - very rare.
  • Cervical cancer (slight increased risk with long term use, likely related to HPV exposure).

Prevention

  • Careful screening using MEC.
  • Patient education on warning signs.
  • Use lowest effective estrogen dose where possible.

Patient education

  • Take one pill daily, same time.
  • What to do if pills missed.
  • Common side effects (often temporary).
  • Serious warning signs (ACHES - Abdominal pain, Chest pain, Headaches, Eye problems, Severe leg pain) - seek help immediately.
  • Does not protect against STIs/HIV - use condoms if needed.
  • Drug interactions.
  • Need for regular follow-up.

Uganda-specific notes

Commonly available method. Low-dose formulations preferred. Important to check BP. Counsel thoroughly about missed pills and interactions, especially with TB meds (Rifampicin) and some ARVs.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 15, Section 15.2.3

  • MOH (2016) / WHO (2020) Medical Eligibility Criteria for Contraceptive Use

    (Referenced for contraindications)

For learning and professional reference. Use current local guidance and clinical judgement.

Browse all conditions

Want notes in PDF? Join our classes!!

Send us a message on WhatsApp
0726113908

Scroll to Top
Enable Notifications OK No thanks